# Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes

> **NCT02307279** · NA · COMPLETED · sponsor: **Gelesis, Inc.** · enrollment: 436 (actual)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DEVICE:** Gelesis100
- **DEVICE:** placebo

## Key facts

- **NCT ID:** NCT02307279
- **Lead sponsor:** Gelesis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307279, "Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT02307279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*